Crean J K, Furlong F, Mitchell D, McArdle E, Godson C, Martin F
University College Dublin, School of Biomolecular and Biomedical Science, Conway Institute of Biomolecular and Biomedical Research, Belfield, Dublin 4, Ireland.
FASEB J. 2006 Aug;20(10):1712-4. doi: 10.1096/fj.05-5010fje. Epub 2006 Jun 21.
Connective tissue growth factor (CTGF/CCN2) is a 38-kDa secreted protein, a prototypic member of the CCN family, which is up-regulated in many diseases, including atherosclerosis, pulmonary fibrosis, and diabetic nephropathy. We previously showed that CTGF can cause actin disassembly with concurrent down-regulation of the small GTPase Rho A and proposed an integrated signaling network connecting focal adhesion dissolution and actin disassembly with cell polarization and migration. Here, we further delineate the role of CTGF in cell migration and actin disassembly in human mesangial cells, a primary target in the development of renal glomerulosclerosis. The functional response of mesangial cells to treatment with CTGF was associated with the phosphorylation of Akt/protein kinase B (PKB) and resultant phosphorylation of a number of Akt/PKB substrates. Two of these substrates were identified as FKHR and p27(Kip-1). CTGF stimulated the phosphorylation and cytoplasmic translocation of p27(Kip-1) on serine 10. Addition of the PI-3 kinase inhibitor LY294002 abrogated this response; moreover, addition of the Akt/PKB inhibitor interleukin (IL)-6-hydroxymethyl-chiro-inositol-2(R)-2-methyl-3-O-octadecylcarbonate prevented p27(Kip-1) phosphorylation in response to CTGF. Immunocytochemistry revealed that serine 10 phosphorylated p27(Kip-1) colocalized with the ends of actin filaments in cells treated with CTGF. Further investigation of other Akt/PKB sites on p27(Kip-1), revealed that phosphorylation on threonine 157 was necessary for CTGF mediated p27(Kip-1) cytoplasmic localization; mutation of the threonine 157 site prevented cytoplasmic localization, protected against actin disassembly and inhibited cell migration. CTGF also stimulated an increased association between Rho A and p27(Kip-1). Interestingly, this resulted in an increase in phosphorylation of LIM kinase and subsequent phosphorylation of cofilin, suggesting that CTGF mediated p27(Kip-1) activation results in uncoupling of the Rho A/LIM kinase/cofilin pathway. Confirming the central role of Akt/PKB, CTGF-stimulated actin depolymerization only in wild-type mouse embryonic fibroblasts (MEFs) compared to Akt-1/3 (PKB alpha/gamma) knockout MEFs. These data reveal important mechanistic insights into how CTGF may contribute to mesangial cell dysfunction in the diabetic milieu and sheds new light on the proposed role of p27(Kip-1) as a mediator of actin rearrangement.
结缔组织生长因子(CTGF/CCN2)是一种38 kDa的分泌蛋白,是CCN家族的典型成员,在包括动脉粥样硬化、肺纤维化和糖尿病肾病在内的多种疾病中表达上调。我们之前发现CTGF可导致肌动蛋白解聚,同时小GTP酶Rho A下调,并提出了一个整合信号网络,将粘着斑溶解和肌动蛋白解聚与细胞极化和迁移联系起来。在此,我们进一步阐述CTGF在人系膜细胞(肾小球硬化症发生过程中的主要靶点)的细胞迁移和肌动蛋白解聚中的作用。系膜细胞对CTGF处理的功能反应与Akt/蛋白激酶B(PKB)的磷酸化以及一些Akt/PKB底物的磷酸化有关。其中两个底物被鉴定为FKHR和p27(Kip-1)。CTGF刺激p27(Kip-1)丝氨酸10位点的磷酸化及其向细胞质的转位。添加PI-3激酶抑制剂LY294002可消除此反应;此外,添加Akt/PKB抑制剂白细胞介素(IL)-6-羟甲基手性肌醇-2(R)-2-甲基-3-O-十八烷基碳酸酯可阻止p27(Kip-1)对CTGF的磷酸化反应。免疫细胞化学显示,在CTGF处理的细胞中,丝氨酸10磷酸化的p27(Kip-1)与肌动蛋白丝末端共定位。对p27(Kip-1)上其他Akt/PKB位点的进一步研究表明,苏氨酸157位点的磷酸化对于CTGF介导的p27(Kip-1)细胞质定位是必需的;苏氨酸157位点的突变可阻止细胞质定位,防止肌动蛋白解聚并抑制细胞迁移。CTGF还刺激Rho A与p27(Kip-1)之间的结合增加。有趣的是,这导致LIM激酶的磷酸化增加以及随后丝切蛋白的磷酸化,表明CTGF介导的p27(Kip-1)激活导致Rho A/LIM激酶/丝切蛋白途径解偶联。与Akt-1/3(PKBα/γ)基因敲除的小鼠胚胎成纤维细胞(MEF)相比,证实了Akt/PKB的核心作用,CTGF仅在野生型MEF中刺激肌动蛋白解聚。这些数据揭示了关于CTGF如何导致糖尿病环境中系膜细胞功能障碍的重要机制见解,并为所提出的p27(Kip-1)作为肌动蛋白重排介质的作用提供了新的线索。